Welcome to McGurk – Intellectual Property Law Blog

Welcome to McGurk – Intellectual Property Law Blog

When I first started my intellectual property (IP) career in 1983, I was a patent examiner in the chemical arts at the United States Patent & Trademark Office (USPTO). I worked in one law firm for 28 years, a second firm for about 2 years, and then started my own firm, McGurk Group LLC, in July 2019. To say that the IP world has changed since my beginnings is an understatement – the laws, number of IP practitioners, litigation practices, courts, and technologies, to name a few, have each evolved. Some for the better and others not so much. When I first started practicing IP and told people that I was a patent attorney, a common refrain was “what’s a patent attorney?” I always found that response amusing but realized how few people new about IP. Fast forward to 2020, those types of comments are rarely uttered. In many parts of our financial ecosystem IP makes the world go round.

My hope is that the McGurk Group Blog (MGB) will serve as a platform to share and discuss IP issues of importance to McGurk Group and others, such as important IP legal developments, precedential legal decisions, issues trending in the USPTO, Patent Trial & Appeal Board (PTAB) updates, decisions and stats. Other favorites of mine include due diligence matters and best practices, and the always important subject of licensing and monetization events. I truly look forward to McGurk Group getting a chance to interact with others regarding IP issues important to all of us. –

MGB is happy to launch its first blog post titled “Covid-19 Update”.

Happy reading!

Michael McGurk

Mike McGurk has more than 30 years of experience in virtually all aspects of patent law. Working with clients ranging from small start-ups to large Fortune 100 companies, he provides counsel in due diligence matters, global portfolio development and adversarial proceedings, including litigation, post-grant reviews, interferences and re-examinations. Mike works primarily with pharmaceutical, chemical, medical device and mechanical technology businesses. For at least the last fifteen (15) years, approximately 50-70% of Mike’s work has been focused in life sciences, including ANDA litigation support and pre-filing due diligence. Mike’s practice is informed by his background as a patent examiner in the chemical arts for the United States Patent and Trademark Office (USPTO), as a litigator for ten years, and as an expert in due diligence matters. He regularly provides strategic litigation counseling support to clients across the nation, and has handled numerous patent matters before the Patent Trial and Appeal Board of the USPTO. His extensive due diligence experience includes pre-litigation, acquisition, in-license, freedom-to-operate product and/or process clearance, design around, validity and patentability matters. Mike works with teams having the appropriate technical and legal abilities.